Results for Selective Estrogen Receptor Mod... translation from English to Slovenian

selective estrogen receptor modulator (serm), atc code:
selektiven modulator estrogenskih receptorjev (serm), oznaka atc:

selective oestrogen receptor modulator, atc code:
farmakoterapevtska skupina: selektivni modulatorji estrogenskega receptorja, oznaka atc:

pharmacotherapeutic group: selective estrogen receptor modulator, atc code: g03xc02.
farmakoterapevtska skupina: selektivni modulator estrogenskih receptorjev (serm); oznaka atc: g03xc02.

pharmaco-therapeutic group: selective oestrogen receptor modulator.
farmakoterapevtska skupina: selektivni modulatorji estrogenskega receptorja.

pharmacotherapeutic group: selective oestrogen receptor modulator, atc code: g03xc01.
farmakoterapevtska skupina: selektivni modulatorji estrogenskega receptorja, oznaka atc: g03xc01.

it belongs to a group of medicines called selective estrogen receptor modulators (serm).
pripada skupini zdravil, ki se imenujejo selektivni modulatorji estrogenskih receptorjev (serm).

fingolimod is a sphingosine 1-phosphate receptor modulator.
fingolimod je modulator receptorja za sfingozin-1-fosfat.

the active substance in optruma, raloxifene, is a selective oestrogen receptor modulator (serm).
zdravilna učinkovina zdravila optruma, raloksifen, je selektivni modulator estrogenskih receptorjev (serm).

bazedoxifene belongs to a class of compounds known as selective estrogen receptor modulators (serms).
bazedoksifen spada v skupino selektivnih modulatorjev estrogenskih receptorjev (serm).

fareston is not recommended for patients with estrogen receptor negative tumours.
fareston ni priporočljiv za bolnice s tumorji brez estrogenskih receptorjev.

bazedoxifene belongs to a group of non-hormonal medicines called selective estrogen receptor modulators (serms).
bazedoksifen spada v skupino nehormonskih zdravil, imenovano selektivni modulatorji estrogenskega receptorja (serm).

ospemifene belongs to a group of medicines that do not contain hormones called selective estrogen receptor modulators (serms).
ospemifene sodi v skupino zdravil, ki ne vsebujejo hormonov, imenovanih selektivni modulatorji estrogenskih receptorjev (serm, selective estrogen receptor modulators).

as a selective oestrogen receptor modulator (serm), raloxifene has selective agonist or antagonist activities on tissues responsive to oestrogen.
kot selektivni modulator estrogenskega receptorja (serm) deluje raloksifen bodisi kot selektivni agonist bodisi kot antagonist na tkiva, ki se odzivajo na estrogen.

the mechanism of action is associated with down-regulation of estrogen receptor protein levels.
mehanizem delovanja je povezan z zmanjšanjem ravni estrogenskega receptorskega (er) proteina.

fulvestrant is a competitive estrogen receptor (er) antagonist with an affinity comparable to estradiol.
fulvestrant je kompetitivni antagonist estrogenskih receptorjev z afiniteto, primerljivo z afiniteto estradiola.

duavive pairs ce with the selective oestrogen receptor modulator (serm), bazedoxifene, which is defined as a tissue selective oestrogen complex (tsec).
zdravilo duavive vsebuje ce in selektivni modulator estrogenskih receptorjev (serm – selective oestrogen receptor modulator) bazedoksifen, kar je opredeljeno kot tkivno selektivni estrogenski kompleks (tsec – tissue selective oestrogen complex).

optruma belongs to a group of non-hormonal medicines called selective oestrogen receptor modulators (serms).
zdravilo optruma sodi v skupino nehormonskih zdravil, imenovano selektivni modulatorji estrogenskega receptorja.

conbriza contains the active substance bazedoxifene, and is a medicine that belongs to a group of non-hormonal medicines called selective estrogen receptor modulators (serms).
zdravilo conbriza vsebuje zdravilno učinkovino bazedoksifen in je zdravilo, ki spada v skupino nehormonskih zdravil z imenom selektivni modulatorji estrogenskih receptorjev (serm).

as observed with other selective estrogen receptor modulators (serms), slightly decreased (approximately 4%) platelet counts were observed in lasofoxifene-treated patients in pearl.
kot pri ostalih zdravilih iz skupine serm (selective estrogen receptor modulators) so pri bolnicah v študiji pearl, ki so bile zdravljene z lasofoksifenom, opazili rahlo zmanjšanje števila trombocitov (za približno 4%).

lasofoxifene is a serm whose biological actions are largely mediated through binding to estrogen receptors.
lasofoksifen je serm, ki biološko učinkuje večinoma prek vezave na estrogenske receptorje.